Last reviewed · How we verify

Cannabis sativa Extract

Roswell Park Cancer Institute · FDA-approved active Small molecule Quality 5/100

Cannabis sativa Extract is a Small molecule drug developed by Roswell Park Cancer Institute. It is currently FDA-approved. Also known as: Cannabis sativa, Cannabis sativa Flowering Top, Cannabis sativa Subsp. Flowering Top Extract, Cannabis sativa Top.

At a glance

Generic nameCannabis sativa Extract
Also known asCannabis sativa, Cannabis sativa Flowering Top, Cannabis sativa Subsp. Flowering Top Extract, Cannabis sativa Top
SponsorRoswell Park Cancer Institute
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Cannabis sativa Extract

What is Cannabis sativa Extract?

Cannabis sativa Extract is a Small molecule drug developed by Roswell Park Cancer Institute.

Who makes Cannabis sativa Extract?

Cannabis sativa Extract is developed and marketed by Roswell Park Cancer Institute (see full Roswell Park Cancer Institute pipeline at /company/roswell-park-cancer-institute).

Is Cannabis sativa Extract also known as anything else?

Cannabis sativa Extract is also known as Cannabis sativa, Cannabis sativa Flowering Top, Cannabis sativa Subsp. Flowering Top Extract, Cannabis sativa Top.

What development phase is Cannabis sativa Extract in?

Cannabis sativa Extract is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing